Antibody Clinical Trials in Paris
6 recruitingParis, France
Showing 1–6 of 6 trials
Recruiting
Phase 2
Safety and Efficacy of Tarperprumig in Adult Participants With Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Alexion Pharmaceuticals, Inc.75 enrolled78 locationsNCT07160608
Recruiting
Phase 1
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
Systemic Lupus Erythematosus (SLE)Systemic Sclerosis (SSc)Lupus Nephritis+2 more
Fate Therapeutics244 enrolled21 locationsNCT06308978
Recruiting
Phase 3
Study of Salvage Therapy to Treat Patients With Granulomatosis With Polyangiitis
Anti-Neutrophil Cytoplasmic Antibody-Associated VasculitisGranulomatosis With Polyangiitis
Assistance Publique - Hôpitaux de Paris42 enrolled1 locationNCT04871191
Recruiting
Peripheral and Intrarenal B Cell Study in Antibody Mediated Transplant Rejection : Phenotypic and Transcriptional Study, Study of Reactivity
Antibody Mediated Rejection After Kidney Transplantation
Assistance Publique - Hôpitaux de Paris45 enrolled2 locationsNCT07134491
Recruiting
Phase 3
Maintaining or Stopping Immunosuppressive Therapy in Patients With ANCA Vasculitis and End-stage Renal Disease
Anti-Neutrophil Cytoplasmic Antibody-Associated VasculitisEnd Stage Renal Disease
Centre Hospitalier Departemental Vendee136 enrolled58 locationsNCT03323476
Recruiting
French Registry for Monitoring Pregnancies for Multiple Sclerosis
Sclerosis, MultipleNeuromyelitis Optica Spectrum DisorderMyelin Oligodendrocyte Glycoprotein (MOG)-Antibody Related Disorders+1 more
Hospices Civils de Lyon1,500 enrolled48 locationsNCT03900221